InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,702.55
(
-0.19%
)
US TECH 100
19,287.60
(
-0.24%
)
Dow Jones
42,063.36
(
0.09%
)
Brent Oil
74.12
(
0.31%
)
Bitcoin
63,613.23
(
-0.01%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

jaybe

Send PM Follow Ignore
Followers 5
Posts 277
Boards Moderated 0
Alias Born 05/29/2011

jaybe

Re: None

Thursday, 06/27/2013 7:51:32 PM

Thursday, June 27, 2013 7:51:32 PM

Post# of 80490
New IST trial for Pona in FGFR2 Endometrial...

Reported by Biomaven on SI board.

Not yet enrolling, very small trial of only 15 pts., but primary outcome is ORR (CR+PR) at 6 months, so should have results at ASCO 2014.

Let's hope the Exclusion Criteria for 'Women and Minorities' is a typo, otherwise this trail could be enrolling for quite some time.

http://clinicaltrials.gov/ct2/show/NCT01888562?term=ponatinib&recr=Open&rank=3
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up